
Keywords: مهار کننده های DPP4; C-IMT; carotid intima-media thickness test; CV; cardiovascular; DPP4; dipeptidyl peptidase-4; DPP4i; DPP4 inhibitors; GLP1; glucagon-like peptide 1; HbA1c; glycated haemoglobin; HF; heart failure; HR; hazard ratio; MACE; major adverse cardiac event; MI;